Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Edigene Therapeutics (Beijing) Inc. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are spread across 2 distinct examiners and 2 distinct art units. This distribution indicates that each pending matter is being reviewed by a different individual in a different technical division of the patent office.
Michael Angelo Riga is the busiest examiner, currently overseeing 1 pending office action. This 1 pending office action is part of the total 2 pending office actions for the company. Because there are 2 distinct art units involved, the company's Biotechnology & Pharmaceuticals innovations are being evaluated by multiple specialized groups. The company must coordinate its responses across 2 distinct examiners to advance its portfolio. This spread across 2 distinct art units necessitates a broad technical approach to prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RIGA, MICHAEL ANGELO | 1 | 57.1% | +61.2% |
| PERSONS, JENNA L | 1 | 50.8% | +61.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684082 | ENGINEERED ADAR-RECRUITING RNAS AND METHODS OF USE THEREOF | RIGA, MICHAEL ANGELO | — |
| 17284232 | METHODS AND COMPOSITIONS FOR EDITING RNAS | PERSONS, JENNA L | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684082 | ENGINEERED ADAR-RECRUITING RNAS AND METHODS OF USE THEREOF | RIGA, MICHAEL ANGELO | 1634 | §102§103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 17284232 | METHODS AND COMPOSITIONS FOR EDITING RNAS | PERSONS, JENNA L | 1637 | §102§103DP | Final Rejection | — | Pending | Jul 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial